OBJECTIVE: Predicting outcome in patients with primary intracerebral haemorrhage (ICH) in the acute stage can provide information to determine the best therapeutic and rehabilitation strategies. We prospectively investigated the predictive value of the functional diffusion map (fDM) in the acute stage of ICH. METHODS: 47 patients with ICH were enrolled for clinical evaluation and MRI within 24 h of symptom onset and 5 days after ICH. Functional diffusion mapping prospectively monitored the apparent diffusion coefficient (ADC) maps of perihaematomal oedema. Consequently, the change in perihaematomal oedema was classified into three categories: increased, decreased, or no significant change. Clinical outcomes were evaluated 6 months after ICH according to the modified Rankin Scale. Correlation between clinical outcome and the fDMs was performed. RESULTS: Among the clinical variables, thalamic haematoma, serum glucose level and National Institutes of Health Stroke Scale scores were significantly different between the good- and poor-outcome groups. The percentage of oedematous tissue undergoing significant change between baseline and Day 5 was also significantly different between the groups. CONCLUSION: fDMs allow for spatial voxel-by-voxel tracking of changes in ADC values. It may be feasible to use fDMs to predict the functional outcome of patients with ICH during the acute stage. Advances in knowledge The use of fDMs for stroke study is demonstrated. fDMs may be more suitable to reflect the pathophysiological heterogeneity within oedemas and may facilitate another thinking process for imaging study of stroke and other neurological diseases.
OBJECTIVE: Predicting outcome in patients with primary intracerebral haemorrhage (ICH) in the acute stage can provide information to determine the best therapeutic and rehabilitation strategies. We prospectively investigated the predictive value of the functional diffusion map (fDM) in the acute stage of ICH. METHODS: 47 patients with ICH were enrolled for clinical evaluation and MRI within 24 h of symptom onset and 5 days after ICH. Functional diffusion mapping prospectively monitored the apparent diffusion coefficient (ADC) maps of perihaematomal oedema. Consequently, the change in perihaematomal oedema was classified into three categories: increased, decreased, or no significant change. Clinical outcomes were evaluated 6 months after ICH according to the modified Rankin Scale. Correlation between clinical outcome and the fDMs was performed. RESULTS: Among the clinical variables, thalamic haematoma, serum glucose level and National Institutes of Health Stroke Scale scores were significantly different between the good- and poor-outcome groups. The percentage of oedematous tissue undergoing significant change between baseline and Day 5 was also significantly different between the groups. CONCLUSION: fDMs allow for spatial voxel-by-voxel tracking of changes in ADC values. It may be feasible to use fDMs to predict the functional outcome of patients with ICH during the acute stage. Advances in knowledge The use of fDMs for stroke study is demonstrated. fDMs may be more suitable to reflect the pathophysiological heterogeneity within oedemas and may facilitate another thinking process for imaging study of stroke and other neurological diseases.
Authors: E Fainardi; M Borrelli; A Saletti; R Schivalocchi; M Russo; C Azzini; M Cavallo; S Ceruti; R Tamarozzi; A Chieregato Journal: Acta Neurochir Suppl Date: 2006
Authors: H Arima; J G Wang; Y Huang; E Heeley; C Skulina; M W Parsons; B Peng; Q Li; S Su; Q L Tao; Y C Li; J D Jiang; L W Tai; J L Zhang; E Xu; Y Cheng; L B Morgenstern; J Chalmers; C S Anderson Journal: Neurology Date: 2009-12-08 Impact factor: 9.910
Authors: Jean-Marc Olivot; Michael Mlynash; Jonathan T Kleinman; Matus Straka; Chitra Venkatasubramanian; Roland Bammer; Michael E Moseley; Gregory W Albers; Christine A C Wijman Journal: Stroke Date: 2010-10-14 Impact factor: 7.914
Authors: Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Gottfried Schlaug; Roland Bammer; Michael P Marks; Gregory W Albers Journal: Stroke Date: 2008-06-19 Impact factor: 7.914
Authors: Ayeesha K Kamal; Jonathan P Dyke; Jeffrey M Katz; Bernardo Liberato; Christopher G Filippi; Robert D Zimmerman; Aziz M Ulug Journal: AJNR Am J Neuroradiol Date: 2003-05 Impact factor: 3.825
Authors: Ken S Butcher; Tracey Baird; Lachlan MacGregor; Patricia Desmond; Brian Tress; Stephen Davis Journal: Stroke Date: 2004-06-03 Impact factor: 7.914
Authors: Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert Journal: J Clin Oncol Date: 2008-06-09 Impact factor: 44.544
Authors: Anirudh Sreekrishnan; Jennifer L Dearborn; David M Greer; Fu-Dong Shi; David Y Hwang; Audrey C Leasure; Sonya E Zhou; Emily J Gilmore; Charles C Matouk; Nils H Petersen; Lauren H Sansing; Kevin N Sheth Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: Vahid Eslami; Pouya Tahsili-Fahadan; Lucia Rivera-Lara; Dheeraj Gandhi; Hasan Ali; Adrian Parry-Jones; Lilli S Nelson; Richard E Thompson; Saman Nekoobakht-Tak; Rachel Dlugash; Nichol McBee; Isaam Awad; Daniel F Hanley; Wendy C Ziai Journal: Stroke Date: 2019-06-10 Impact factor: 7.914
Authors: Gary D Luker; Huong Marie Nguyen; Benjamin A Hoff; Craig J Galbán; Diego Hernando; Thomas L Chenevert; Moshe Talpaz; Brian D Ross Journal: Tomography Date: 2016-03